VR Logo

Aurobindo Pharma Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

38 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1986

Chairman: K Ragunathan

Managing Director: N Govindarajan

Group: Aurobindo

Listing: NSE: AUROPHARMA, BSE: 524804

Headquarters: Hyderabad, Telangana

Website: www.aurobindo.com

Key Facts

Market cap: R 29,537.17 Cr

Revenue (TTM): R 22,232.27 Cr

Earnings (TTM): R 2,562.12 Cr

Cash: R 1,957.20 Cr

Total Debt: R 6,966.76 Cr

Promoters' ownership: 51.87%

Liquidity: High

52 Week range: R 389.35 - 838.00

Face value: R1.00

Shares outstanding: 58,59,38,609

Stock Performance

Time Period Aurobindo Pharma S&P BSE Healthcare S&P BSE Mid Cap
YTD10.325.783.18
1 month0.580.69-2.39
3 months17.526.014.79
1 Year-30.934.548.94
3 Years-8.88-2.534.50
5 Years-0.58-1.987.56
10 Years18.4011.389.32
As on 24-Feb-2020
Year Aurobindo Pharma S&P BSE Mid Cap S&P BSE Healthcare
2019-37.69-3.05-3.55
20186.50-13.31-5.89
20172.7948.130.49
2016-24.067.97-12.88
201555.437.4315.06
2014189.9454.6947.43
2013103.05-5.7322.55

Review & Analysis